A recent clinical trial is offering hope for people living with a specific type of metastatic colorectal cancer (mCRC). Researchers found that combining immunotherapy with chemotherapy and targeted therapy may help patients live longer without their cancer growing or spreading compared to immunotherapy alone. The findings come from the phase III COMMIT trial, which was […]

The American Cancer Society (ACS) has updated its colorectal cancer (CRC) screening guidelines, giving patients more screening options than ever before. While colonoscopy remains the gold standard for detecting colorectal cancer, the updated recommendations now include new FDA-approved blood tests and at-home stool tests that may help more people get screened. The message from experts […]

Every year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together cancer researchers, oncologists, and advocates to discuss the latest advances in cancer care. Some studies presented at ASCO may eventually change how colorectal cancer (CRC) is treated. Others help answer important questions patients and families are already asking in clinic. Here are […]

For people living with HER2-positive metastatic colorectal cancer (CRC), treatment options can feel limited, especially when standard chemotherapy stops working. But new research presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting offers encouraging news: a targeted therapy called trastuzumab deruxtecan (Enhertu) may help patients live longer than standard chemotherapy, particularly when […]

March is Colorectal Cancer (CRC) Awareness Month and we’re spotlighting strategies that can help bolster screening rates. In recent years, CRC rates have increased in people under 50 years old, emphasizing the importance of early detection. Recognizing this, the U.S. Preventive Services Task Force lowered the recommended screening age from 50 to 45 in 2021. […]

Emerging research suggests that long-term alcohol consumption, especially heavy drinking, may increase the risk of developing colorectal cancer (CRC). While drinking alcohol doesn’t guarantee someone will develop cancer, understanding how lifestyle choices influence risk can help patients make informed health decisions. What is colorectal cancer? CRC is cancer that begins in the colon or rectum. […]

The 2026 ASCO Gastrointestinal (GI) Cancers Symposium showcased important new findings that may change how colorectal cancer (CRC) is prevented, treated, and managed. From advances in targeted and combination therapies to evidence that simple lifestyle changes can improve quality of life, this blog highlights key takeaways and what they could mean for patients moving forward. […]

New research is reshaping how experts understand colorectal cancer (CRC). In this Q&A, MD Anderson Cancer Center’s Dr. Scott Kopetz highlights the latest trends, from early-onset disease to lifestyle-related findings, and explains what the growing body of data means for patients and families. Watch the full webinar The following questions and responses have been lightly […]

Colorectal cancer (CRC) is one of the most common cancers, but it’s also one of the most preventable and treatable when found early. With ongoing research, there are now more ways than ever to catch CRC sooner and treat it more effectively. Here’s what’s new in prevention, screening, and treatment. New blood-based screening options Screening […]

Each year, the American Society of Clinical Oncology (ASCO) hosts its Annual Meeting in Chicago. This conference brings oncology professionals from across the globe and showcases the clinical breakthroughs in cancer care. We’ve put together some of the exciting colorectal cancer advancements unveiled at this event below. Data reveals the significance of physical activity after […]